One Million Visitors and the Power of Early Detection

Reaching one million visitors is more than a milestone for MyBrainGuide. It is proof that trusted, accessible information can make a real difference in people’s lives.

Congress Increases Funding for Alzheimer’s Disease and Other Dementia Research

House and Senate Committees on appropriations released their final bipartisan FY2026 Labor–Health and Human Services–Education appropriations bill.

UsAgainstAlzheimer’s Statement on Initial Findings from Novo Nordisk Alzheimer’s EVOKE and EVOKE+ Trials

UsAgainstAlzheimer’s released the following statement after Novo Nordisk announced results from its phase 3 EVOKE and EVOKE+ trials.

This November, we’re honoring Alzheimer’s Awareness Month.

Understand your brain health today — and take the first step with BrainGuide.

UsAgainstAlzheimer’s Applauds Senate Appropriators for Robust Investments in Alzheimer’s Programs

These significant investments in research underscore the millions of Americans impacted by Alzheimer’s and other dementias.

Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

One Million Visitors and the Power of Early Detection

Congress Increases Research Funding

Statement on Initial Findings from Novo Nordisk Alzheimer’s EVOKE and EVOKE+ Trials

Early detection can change lives.

UsAgainstAlzheimer’s Applauds Robust Investments in Alzheimer’s Programs

Become a Member

VISION: UsAgainstAlzheimer's envisions a world without Alzheimer's where brainspan equals lifespan. 

MISSION: Catalyze change in the health ecosystem to improve dementia prevention, early detection, and access to treatments through advocacy, policy, convening, and high-leveraged programs, with a particular focus on health equity.   

 

Prevention

Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.

CLICK HERE FOR MORE INFO

Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.

CLICK HERE FOR MORE INFO

Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.

CLICK HERE FOR MORE INFO

 

Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • April 16, 2024

    UsAgainstAlzheimer’s Appoints Vivian Vasallo as Vice President for Early Detection

    UsAgainstAlzheimer’s Appoints Vivian Vasallo as Vice President for Early Detection

    Read more
  • April 10, 2024

    UsAgainstAlzheimer’s Statement on Selection of Rep. Tom Cole's as Next House Appropriations Chair

    UsAgainstAlzheimer’s released the following statement in response to the appointment of U.S...

    Read more
  • March 25, 2024

    Congress Passes Bill Making Major Investments in Alzheimer’s

    Bill Increases Funding for Alzheimer’s Research and Prevention Efforts

    Read more
  • March 20, 2024

    Important Alzheimer’s Bills Advance in Congress

    Read more
  • March 08, 2024

    FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s

    Agency to convene an advisory committee to consider the drug.

     

    Read more
  • February 08, 2024

    Organizations Unite to Improve Brain Health

    UsAgainstAlzheimer’s Launches Business Collaborative for Brain Health with founding partners AARP, GN...

    Read more

Reports

  • Resources
    report

    2024 Annual Report

  • Resources
    2023 report

    2023 Annual Report

  • Resources

    2022 Annual Report